Skip to main content
. 2018 Feb 15;24:40–46. doi: 10.12659/MSMBR.907333

Figure 3.

Figure 3

RUNX1 is a direct target of miR-144 in ovarian cancer cells. (A) The putative miR-144-binding sites are shown. (B) The wild-type RUNX1 3-UTR (Wt) or mutant RUNX1 3′UTR (Mut) plasmid co-transfected with miR-144, miR-NC, or miR-Ctrl. Luciferase activity was determined in SKOV3 and OVCAR3 cells.